Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3171691000168113 | Praluent (alirocumab 150 mg / 1 mL) injection, 1 mL pen device (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3171701000168113 | Praluent 150 mg/mL injection, pen device | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Praluent 150 mg/mL injection, pen device | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Praluent 150 mg/mL injection, pen device | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Praluent 150 mg/mL injection, pen device | Is a | Praluent | true | Inferred relationship | Some | ||
| Praluent 150 mg/mL injection, pen device | Is a | alirocumab 150 mg/mL injection, pen device | true | Inferred relationship | Some | ||
| Praluent 150 mg/mL injection, pen device | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
| Praluent 150 mg/mL injection, pen device | has unit of use | pen device | true | Inferred relationship | Some | 475085911 | |
| Praluent 150 mg/mL injection, pen device | has intended active ingredient | alirocumab | true | Inferred relationship | Some | 475085910 | |
| Praluent 150 mg/mL injection, pen device | has Australian BoSS | alirocumab | true | Inferred relationship | Some | 475085910 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Praluent 150 mg/mL injection, 1 mL pen device | has TPUU | True | Praluent 150 mg/mL injection, pen device | Inferred relationship | Some | 1 |
| Praluent 150 mg/mL injection, 1 mL pen device | has TPUU | True | Praluent 150 mg/mL injection, pen device | Inferred relationship | Some | 1 |
| Praluent 150 mg/mL injection, 6 x 1 mL pen devices | has TPUU | True | Praluent 150 mg/mL injection, pen device | Inferred relationship | Some | 1 |
| Praluent (alirocumab 150 mg / 1 mL) injection, 2 x 1 mL pen devices (trade product pack) | has TPUU | True | Praluent 150 mg/mL injection, pen device | Inferred relationship | Some | 1 |
| Praluent 150 mg/mL injection, 2 x 1 mL pen devices | has TPUU | True | Praluent 150 mg/mL injection, pen device | Inferred relationship | Some | 1 |
| Praluent 150 mg/mL injection, 6 x 1 mL pen devices | has TPUU | True | Praluent 150 mg/mL injection, pen device | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR